Signature Resources Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Signature Resources Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.78K	Hold	83	–	–	﹤0.01%	430
2026 Q1	$5.03K	Buy	83 +41	+98%	+$2.39K	﹤0.01%	383
2025 Q4	$2.27K	Buy	42 +19	+83%	+$914	﹤0.01%	469
2025 Q3	$1.04K	Hold	23	–	–	﹤0.01%	469
2025 Q2	$1.06K	Buy	+23	New	+$1.13K	﹤0.01%	473
2024 Q4	–	Sell	-57	Closed	-$2.95K	–	375
2024 Q3	$2.95K	Hold	57	–	–	﹤0.01%	287
2024 Q2	$2.37K	Buy	+57	New	+$2.55K	﹤0.01%	316

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Signature Resources Capital Management's BMY Position: Q2 2026 in Review

Signature Resources Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 83 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

Signature Resources Capital Management first reported a position in BMY in Q2 2024 and has held it in 7 quarters since. The position peaked at $5.03K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Signature Resources Capital Management held 83 shares of Bristol-Myers Squibb worth $4.78K as of Q2 2026.
Signature Resources Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #430 holding.
Signature Resources Capital Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 7 quarters since.
Signature Resources Capital Management's Bristol-Myers Squibb position peaked at $5.03K in Q1 2026.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.